Literature DB >> 9595593

"Full recovery" from schizophrenia in the long term: a ten-year follow-up of eight former schizophrenic patients.

A K Torgalsbøen1, B R Rund.   

Abstract

The present study reports longitudinal data on individuals who ten years ago were fully recovered from a previously diagnosed schizophrenia. Seven out of ten subjects consented and were reexamined at the present follow-up, and data on an eighth subject was secured elsewhere. A semistructured interview was used to examine psychosocial functioning of the subjects in the follow-up period. Out of the six subjects with a confirmed diagnosis of schizophrenia, only three subjects were still fully recovered; one had a deteriorating course and two had a fluctuating course of illness. The results from the study indicate that recovery from schizophrenia may take the form of time-limited remissions for half of the reexamined subjects when strict criteria for full recovery are used. Protective factors such as willpower, a (partly) intact capacity for object attachment, and a supportive family may be important prerequisites for recovery. Two different courses of schizophrenia are illustrated by cases.

Entities:  

Mesh:

Year:  1998        PMID: 9595593     DOI: 10.1080/00332747.1998.11024816

Source DB:  PubMed          Journal:  Psychiatry        ISSN: 0033-2747            Impact factor:   2.458


  3 in total

1.  Empowerment and its associations in schizophrenia: a cross-sectional study.

Authors:  Amlan Kusum Jana; Daya Ram; Samir Kumar Praharaj
Journal:  Community Ment Health J       Date:  2014-05-03

2.  Implementing recovery oriented evidence based programs: identifying the critical dimensions.

Authors:  Marianne Farkas; Cheryl Gagne; William Anthony; Judi Chamberlin
Journal:  Community Ment Health J       Date:  2005-04

3.  Symptomatic remission in a multiracial urban population of older adults with schizophrenia.

Authors:  Azziza Bankole; Carl I Cohen; Ipsit Vahia; Shilpa Diwan; Nikhil Palekar; Pia Reyes; Mamta Sapra; Paul M Ramirez
Journal:  Am J Geriatr Psychiatry       Date:  2008-12       Impact factor: 4.105

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.